199 related articles for article (PubMed ID: 37812652)
21. BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma.
Puls F; Niblett A; Marland G; Gaston CL; Douis H; Mangham DC; Sumathi VP; Kindblom LG
Am J Surg Pathol; 2014 Oct; 38(10):1307-18. PubMed ID: 24805859
[TBL] [Abstract][Full Text] [Related]
22. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.
Dubois SG; Epling CL; Teague J; Matthay KK; Sinclair E
Pediatr Blood Cancer; 2010 Jan; 54(1):13-8. PubMed ID: 19711435
[TBL] [Abstract][Full Text] [Related]
24. Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trial.
Frank JA; Ranft A; Paulussen M; Juergens H; Kruseova J; Bauer S; Niggli F; Reichardt P; Dirksen U
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436593
[TBL] [Abstract][Full Text] [Related]
25. Ewing sarcoma family of tumors-derived small extracellular vesicle proteomics identify potential clinical biomarkers.
Samuel G; Crow J; Klein JB; Merchant ML; Nissen E; Koestler DC; Laurence K; Liang X; Neville K; Staggs V; Ahmed A; Atay S; Godwin AK
Oncotarget; 2020 Aug; 11(31):2995-3012. PubMed ID: 32821345
[TBL] [Abstract][Full Text] [Related]
26. Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo.
Lacroix J; Kis Z; Josupeit R; Schlund F; Stroh-Dege A; Frank-Stöhr M; Leuchs B; Schlehofer JR; Rommelaere J; Dinsart C
Viruses; 2018 Jun; 10(6):. PubMed ID: 29865280
[TBL] [Abstract][Full Text] [Related]
27. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.
Weiner AK; Radaoui AB; Tsang M; Martinez D; Sidoli S; Conkrite KL; Delaidelli A; Modi A; Rokita JL; Patel K; Lane MV; Zhang B; Zhong C; Ennis B; Miller DP; Brown MA; Rathi KS; Raman P; Pogoriler J; Bhatti T; Pawel B; Glisovic-Aplenc T; Teicher B; Erickson SW; Earley EJ; Bosse KR; Sorensen PH; Krytska K; Mosse YP; Havenith KE; Zammarchi F; van Berkel PH; Smith MA; Garcia BA; Maris JM; Diskin SJ
bioRxiv; 2024 Jan; ():. PubMed ID: 38106022
[TBL] [Abstract][Full Text] [Related]
28. An
Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
[TBL] [Abstract][Full Text] [Related]
29. Nutlin-3a is a potential therapeutic for ewing sarcoma.
Pishas KI; Al-Ejeh F; Zinonos I; Kumar R; Evdokiou A; Brown MP; Callen DF; Neilsen PM
Clin Cancer Res; 2011 Feb; 17(3):494-504. PubMed ID: 21098696
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and oncologic outcomes of patients with Ewing sarcoma of the scapula.
Yeung CM; Kaiser CL; Peleteiro-Pensado M; Barrientos-Ruiz I; Ortiz-Cruz EJ; Anderson ME; Raskin KA; Lozano-Calderón SA
Surg Oncol; 2021 Sep; 38():101619. PubMed ID: 34157657
[TBL] [Abstract][Full Text] [Related]
31. Combinatorial Drug Screening Identifies Ewing Sarcoma-specific Sensitivities.
Radic-Sarikas B; Tsafou KP; Emdal KB; Papamarkou T; Huber KV; Mutz C; Toretsky JA; Bennett KL; Olsen JV; Brunak S; Kovar H; Superti-Furga G
Mol Cancer Ther; 2017 Jan; 16(1):88-101. PubMed ID: 28062706
[TBL] [Abstract][Full Text] [Related]
32. Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets.
Baldauf MC; Orth MF; Dallmayer M; Marchetto A; Gerke JS; Rubio RA; Kiran MM; Musa J; Knott MML; Ohmura S; Li J; Akpolat N; Akatli AN; Özen Ö; Dirksen U; Hartmann W; de Alava E; Baumhoer D; Sannino G; Kirchner T; Grünewald TGP
Oncotarget; 2018 Jan; 9(2):1587-1601. PubMed ID: 29416716
[TBL] [Abstract][Full Text] [Related]
33. Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma.
Puerto-Camacho P; Amaral AT; Lamhamedi-Cherradi SE; Menegaz BA; Castillo-Ecija H; Ordóñez JL; Domínguez S; Jordan-Perez C; Diaz-Martin J; Romero-Pérez L; Lopez-Alvarez M; Civantos-Jubera G; Robles-Frías MJ; Biscuola M; Ferrer C; Mora J; Cuglievan B; Schadler K; Seifert O; Kontermann R; Pfizenmaier K; Simón L; Fabre M; Carcaboso ÁM; Ludwig JA; de Álava E
Clin Cancer Res; 2019 Apr; 25(7):2228-2240. PubMed ID: 30420447
[TBL] [Abstract][Full Text] [Related]
34. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.
Balestra T; Manara MC; Laginestra MA; Pasello M; De Feo A; Bassi C; Guerzoni C; Landuzzi L; Lollini PL; Donati DM; Negrini M; Magnani M; Scotlandi K
Mol Cancer Ther; 2022 Jan; 21(1):58-69. PubMed ID: 34667115
[TBL] [Abstract][Full Text] [Related]
35. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
36. High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma.
Haveman LM; van Ewijk R; van Dalen EC; Breunis WB; Kremer LC; van den Berg H; Dirksen U; Merks JH
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011406. PubMed ID: 34472084
[TBL] [Abstract][Full Text] [Related]
37. [Ewing sarcomas and Ewing-like sarcomas : New aspects].
Specht K; Hartmann W
Pathologe; 2018 Mar; 39(2):154-163. PubMed ID: 29480450
[TBL] [Abstract][Full Text] [Related]
38. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
[TBL] [Abstract][Full Text] [Related]
39. Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.
Pascual-Pasto G; Resa-Pares C; Castillo-Ecija H; Aschero R; Baulenas-Farres M; Vila-Ubach M; Burgueño V; Balaguer-Lluna L; Cuadrado-Vilanova M; Olaciregui NG; Martinez-Velasco N; Perez-Jaume S; de Alava E; Tirado OM; Lavarino C; Mora J; Carcaboso AM
Biochem Pharmacol; 2023 Feb; 208():115408. PubMed ID: 36603685
[TBL] [Abstract][Full Text] [Related]
40. CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.
De Feo A; Manfredi M; Mancarella C; Maqueda JJ; De Giorgis V; Pignochino Y; Sciandra M; Cristalli C; Donadelli M; Scotlandi K
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
